Published in AIDS Weekly, December 14th, 1998
The AlphaVax research team is one of two groups chosen by IAVI to accelerate AIDS vaccine development. The other team is based in Oxford, United Kingdom. IAVI's total funding commitment of $9.1 million represents the two single largest AIDS research awards ever by a non-governmental organization, IAVI said in a news release.
The AlphVax team is led by Robert Olmsted, PhD, and Robert Johnston, PhD, Durham, North Carolina. AlphaVax plans to collaborate with the University of Capetown in South...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.